Skip to main navigation

+44 (0)20 8154 4600
info@achillestx.com

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Events & Presentations

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Upcoming Events

Apr 23 - Apr 24 2024

Immuno-Oncology Summit Europe

Apr 29 - Apr 30 2024

LSX World Congress

Apr 29 2024 at Time:10:00 AM EDT

Chardan’s 8th Annual Cell Therapy Manufacturing Summit (Virtual)

Past Events

Year

All Events
2024
2023

Feb 29 2024 at Time:10:30 AM EST

10th Annual Immuno-Oncology 360 Conference (IO360)

Corporate Presentations

Achilles Therapeutics Corporate Presentation – April 2024

IO Summit EU 2023 - Personalised Neoantigen Therapies: State of the Art Neoantigen Immunogenicity Prediction

SAE Cell and Gene Therapy 2023 - Targeting Clonal Neoantigens in Cancer

Achilles Therapeutics PI/IIa CHIRON & THETIS Interim Update – Dec 6, 2022

ESMO IO 2022 Poster - Early Proof of Concept of Safety and Clinical Activity of cNeT

ESMO IO 2021 Poster 58P: Achilles VELOS Process 2 generates a >10-fold improvement in cNeT dose over Process 1 with a highly potent polyclonal phenotype

SITC 2021 Poster 193: The Achilles VELOS Process 2 boosts the dose of highly functional cNeT

SITC 2021 Poster 543: Sensitive quantification and tracking of the active components of cNeT

ESGCT 2021 OR54: Multicentre, prospective research protocol for development of a clonal neoantigen-reactive T cell therapy pipeline across multiple tumour types:

ASCO 2021 Poster TPS9138: An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON)

AACR 2021 Poster 1508: Characterization of a novel clonal neoantigen reactive T cell (cNeT) product

Print Page

RSS Feeds

Email Alerts

Contact IR

Home
About Us
Science
Publications
Pipeline
Investors & Media
Work with us
Contact

UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK

US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108

+44 (0)20 8154 4600
info@achillestx.com

© Copyright - Achilles Therapeutics plc.

Achilles Therapeutics plc (13027460) is registered in England and Wales. The registered office is at 245 Hammersmith Road, London, W6 8PW.

Privacy & Cookie Policy

Terms & Conditions